Add a bookmark to get started

Charles Adelson

Charles N. Adelson, Ph.D.

Patent Agent
About

Dr. Charles Adelson is a registered patent agent in DLA Piper’s Prosecution practice, where he advises clients on patent portfolio and prosecution strategies as well as freedom-to-operate, invalidity, and noninfringement analyses. Charles’ practice focuses on patent prosecution spanning life sciences, chemical, and diagnostic technologies, including biologic and small molecule therapeutics, antibody-drug conjugates biomolecule and organism engineering, transfection methods, novel polysaccharides, and biological assays. 

During his doctoral studies, Charles correlated enzyme structure and function in redox-active biological sites to guide protein and synthetic catalyst design and to elucidate disease-mutation relationships. His research involved spectroscopic, magnetic, and biological characterization techniques, as well as quantum mechanical theory formulation for protein-metal ion covalency quantitation. During his Ph.D., Charles also prospected a CO2 remediation technology in the Stanford Climate Ventures startup incubator.

Charles is not a lawyer.

Bar admissionsUnited States Patent and Trademark Office

EXPERIENCE

  • Represented biologics startup in $177 million IPO
  • Represented companies and investors in IP due diligences
  • Represented pharmaceutical companies developing cancer, antibiotic, ocular, and cell-based therapeutics
  • Represented medical diagnostics companies during diagnostic platform development
Education
  • B.A., Chemistry, Grinnell College 2012
    with honors
  • Ph.D., Stanford University 2019

Publications

  • Co-author, et al. Characterization of the preprocessed copper site in amine oxidase and assignment of the reactive copper site in topaquinone biogenesis. Journal of the American Chemical Society, 2019, 141(22):8877-8890
  • Co-author with Vermesh, O., Aalipour, A., Ge, T. J., Saenz, Y., Gui, Y., Alam, I. S., Park, S., et al. An intravascular magnetic wire for the high-throughput retrieval of circulating tumour cells in vivo. Nature Biomedical Engineering, 2018, 2, 696-705

Connect

Phone

+1 415 615 6108
(Work, San Francisco)
+1 206 839 4908
(Work, Seattle)